Results 131 to 140 of about 7,093,593 (187)

Most-Favored-Nation pricing meets Joint Clinical Assessment: early evidence of compounding pressure on European drug launches. [PDF]

J Comp Eff Res
Ramagopalan SV, Ryan ML.
europepmc   +1 more source

Individualized pharmacotherapy: background and development. [PDF]

Ann Transl Med
Jørgensen JT, Westergaard N.
europepmc   +1 more source

Defining core competencies for advanced therapy medicinal products translation. [PDF]

Front Digit Health
Guillen E, Hidalgo-Simon A.
europepmc   +1 more source

Advances in cell therapy for solid tumours: European perspective and future directions. [PDF]

Lancet Reg Health Eur
Moreno V, Thistlethwaite F, Yarza R, Tak WS, Lim KHJ, Haanen JBAG.   +5 more
europepmc   +1 more source

Editorial: Clinical translation and commercialisation of advanced therapy medicinal products, volume II. [PDF]

Front Bioeng Biotechnol
Bayon Y, Vertès AA.
europepmc   +1 more source

Regulatory Challenges and Opportunities for Cell-Derived Extracellular Vesicles in Pharmaceutical Development: A European and Global Perspective. [PDF]

J Extracell Vesicles
Limongi T, Milla P, Stella B, Arpicco S.
europepmc   +1 more source

Using Genomic Data in Personalized Oncology Medicine: An Exploratory Expert-Elicitation Study with Narrative Regulatory Mapping of Regulations, Implementations, and Challenges in Saudi Arabia. [PDF]

Healthcare (Basel)
Hakami L, Alnaim L, Almoaikel K, Alharbi J.   +3 more
europepmc   +1 more source

General Commentary: From hospital exemption to evidence: a statistical framework for leveraging real-world data. [PDF]

Front Immunol
Brigiari G, Muraca M, Gregori D.
europepmc   +1 more source

Fracture healing: from molecular and cellular mechanisms to therapeutic strategies. [PDF]

Signal Transduct Target Ther
Staubli F, Ten Ham RMT, Bergsma JE, Gawlitta D, Man K.   +4 more
europepmc   +1 more source

Hospital exemption use of virus-specific T-lymphocytes in children: early experience within the Allovista clinical trial framework. [PDF]

Front Immunol
Ussowicz M, Ślęzak A, Myszka-Kozłowska M, Gajek K, Jopek K, Bukowska M, Bukowska A, Jureczek J, Jarmużek W, Litwin M, Deręgowski M, Derwich K, Czyż A, Bogacz A.   +13 more
europepmc   +1 more source